Dutch food and nutrition group Royal Numico has announced that an agreement in principle has been reached to sell its subsidiaries Biodermal and Galenco, including the related production facility in Belgium, to Omega Pharma (Belgium).

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

The combined sales of the two subsidiaries, which are specialised in skincare products, amounted to approximately €15m (US$15.8m) in 2002.

It is expected that the sale will be finalised by the end of March 2003.

Numico has said that these divestments are in line with the strategic review of the company as announced in November 2002, whereby the company will focus on its core activities baby food and clinical nutrition.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Just Food Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Just Food Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now